Dr Peter Houweling is a Team leader and senior research officer in the Muscle Research group at the Murdoch Children’s Research Institute (MCRI). He completed his PhD at the University of Sydney and post-doctoral appointments at the Children’s Hospital Westmead, before moving the MCRI in 2013.
He has almost 15 years of experience in the laboratory where he is working to understand the impact of genetic variants on skeletal muscle performance in health and disease.
His Team now focuses on using stem cells to model and test new treatments for patients with genetic muscle diseases, including Duchenne muscular dystrophy (DMD), Facioscapulohumeral muscular dystrophy (FSHD) and other congenital muscular dystrophies.
Dr Peter Houweling is a Team leader and senior research officer in the Muscle Research group at the Murdoch Children’s Research Institute (MCRI). He completed his PhD at the University of Sydney and post-doctoral appointments at the Children’s...
Dr Peter Houweling is a Team leader and senior research officer in the Muscle Research group at the Murdoch Children’s Research Institute (MCRI). He completed his PhD at the University of Sydney and post-doctoral appointments at the Children’s Hospital Westmead, before moving the MCRI in 2013.
He has almost 15 years of experience in the laboratory where he is working to understand the impact of genetic variants on skeletal muscle performance in health and disease.
His Team now focuses on using stem cells to model and test new treatments for patients with genetic muscle diseases, including Duchenne muscular dystrophy (DMD), Facioscapulohumeral muscular dystrophy (FSHD) and other congenital muscular dystrophies.
Top Publications
Girgis, CM, Cha, KM, So, B, Tsang, M, Chen, J, Houweling, PJ, Schindeler, A, Stokes, R, Swarbrick, MM, Evesson, FJ, et al.
Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function.
Journal of Cachexia Sarcopenia and Muscle
10(6)
:
1228 -1240
2019
view publication
Seto, JT, Garton, FC, North, KN, Houweling, PJ.
ΑLpha-Actinin-3’s Role in the Genetic Control of Muscle Strength and Performance.
323 -343
2019
view publication
Del Coso, J, Hiam, D, Houweling, P, Pérez, LM, Eynon, N, Lucía, A.
More than a ‘speed gene’: ACTN3 R577X genotype, trainability, muscle damage, and the risk for injuries.
European Journal of Applied Physiology
119(1)
:
49 -60
2019
view publication
Houweling, PJ, Papadimitriou, ID, Seto, JT, Pérez, LM, Del Coso, J, North, KN, Lucia, A, Eynon, N.
Is evolutionary loss our gain? The role of ACTN3 p.Arg577Ter (R577X) genotype in athletic performance, ageing, and disease.
Human Mutation
39(12)
:
1774 -1787
2018
view publication
Papadimitriou, ID, Lockey, SJ, Voisin, S, Herbert, AJ, Garton, F, Houweling, PJ, Cieszczyk, P, Maciejewska-Skrendo, A, Sawczuk, M, Massidda, M, et al.
No association between ACTN3 R577X and ACE I/D polymorphisms and endurance running times in 698 Caucasian athletes.
BMC Genomics
19(1)
:
13
2018
view publication